MedPath

Effectiveness study of steroid in severe community acquired pneumonia

Not Applicable
Conditions
Health Condition 1: J189- Pneumonia, unspecified organism
Registration Number
CTRI/2022/02/040039
Lead Sponsor
Dr Mehta Childrens hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All consecutive children aged 1month to 60 months admitted to PICU with ââ?¬Å?severe pneumonia requiring oxygen therapyââ?¬? would be enrolled in this study after getting informed consent from parents.

Exclusion Criteria

1.Children diagnosed to have chronic lung disease

2.Any child hospitalized for respiratory illness in last one month period

3.Children previously diagnosed to have bronchial asthma

4.Children receiving home mechanical ventilation

5.Children diagnosed to have preexisting neuromuscular disease

6.Children diagnosed to have pre existing adrenal insufficiency

7.Children diagnosed to have empyema at admission to emergency room

8.Children diagnosed to have pre existing immunocompromised conditions

9.Children diagnosed to have Tuberculosis before admission

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome parameter in patients after randomisation to steroid and placebo group is the duration of oxygen therapy ( in hours) during the first 5 days of admissionTimepoint: The primary outcome parameter in patients after randomisation to steroid and placebo group is the duration of oxygen therapy ( in hours) during the first 5 days of admission
Secondary Outcome Measures
NameTimeMethod
Rise in secondary infections , Complications like - hyperglycemia , Gastrointestinal bleeding , hypertension .Timepoint: Till the time child is admitted in PIC
© Copyright 2025. All Rights Reserved by MedPath